Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi

Disclosed are imidazolidinone compounds of general formula: wherein R represents a substituted or unsubstituted 5- or 6-membered nitrogen-containing heterocyclic monocyclic group; the ring A represents a substituted or unsubstituted phenyl group; Y represents vinylene group or ethynylene group; m re...

Full description

Saved in:
Bibliographic Details
Main Authors OCHIAI, TAKASHI, INAGE, MASARU, WADA, HIROSHI, TAKEDA, MIKIO, TAMAKI, HAJIME
Format Patent
LanguageFinnish
Swedish
Published 31.12.1993
Edition5
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are imidazolidinone compounds of general formula: wherein R represents a substituted or unsubstituted 5- or 6-membered nitrogen-containing heterocyclic monocyclic group; the ring A represents a substituted or unsubstituted phenyl group; Y represents vinylene group or ethynylene group; m represents 1 to 6; n represents 0, 1 or 2; and Q represents methylene group or a single bond, or a salt thereof, a process for preparing the same, a pharmaceutical composition comprising the same as an active ingredient, and the use of the same for the manufacture of a medicament for the treatment of depression or peptic ulcers, as an activator of cerebral metabolism, as an agent having a nootropic effect, or for use as a brain activator.
Bibliography:Application Number: FI19870004865